Transformation by different oncogenes relies on specific metabolic adaptations

Area of Science:

• Oncology
• Cell Biology
• Metabolic Research

Background:

• Metabolic reprogramming is a hallmark of cancer, crucial for tumor progression.
• Understanding oncogene-driven metabolic shifts is key to developing targeted therapies.
• NIH 3T3 cells provide a model to study specific oncogene-induced metabolic changes.

Purpose of the Study:

• To compare the distinct metabolic adaptations induced by H-RAS and a mutant histone deacetylase 4 (HDAC4) in NIH 3T3 cells.
• To investigate the role of glycolysis and mitochondrial respiration in oncogene-induced cellular transformation.
• To explore metabolic changes beyond the Warburg effect in cancer models.

Main Methods:

• In vitro transformation of NIH 3T3 cells using H-RAS and HDAC4/TM oncogenes.
• Comparative analysis of cellular metabolism, including glycolytic enzyme activity, oxygen consumption, and ATP levels.
• Assessment of mitochondrial complex I activity and lactate secretion.

Main Results:

• H-RAS transformation led to a pronounced Warburg effect: increased glycolysis, reduced oxygen consumption, and impaired mitochondrial complex I.
• HDAC4/TM transformation showed modest glycolysis upregulation but increased mitochondrial oxygen consumption.
• Glycolysis was essential for ATP production and proliferation in RAS-transformed cells.

Conclusions:

• Cellular transformation and tumor progression can occur via distinct metabolic adaptations.
• HDAC4/TM-transformed cells offer a valuable model for studying oncogene-driven metabolic alterations beyond the canonical Warburg effect.
• These findings highlight the metabolic plasticity of cancer cells and potential therapeutic targets.